Author:
Hurwitz Kathleen A.,Ingulli Elizabeth G.,Krous Henry F.
Subject
Neurology (clinical),Developmental Neuroscience,Neurology,Pediatrics, Perinatology and Child Health
Reference13 articles.
1. UCB Pharma Inc. Approved drug therapies. NDA 21–035. Levetiracetam. Revised Dec. 1, 1999. Available at: http://www.fda.gov/cder/foi/label/1999/21035lbl.pdf. Accessed July, 2008.
2. Safety profile on levetiracetam;Arroyo;Epileptic Disord,2003
3. Pharmacokinetic profile of levetiracetam: toward ideal characteristics;Patsalos;Pharmacol Ther,2000
4. Levetiracetam monotherapy in children with epilepsy;Khurana;Pediatr Neurol,2007
5. Levetiracetam for benign epilepsy of childhood with centrotemporal spikes: 3 cases;Bello-Espinosa;Seizure,2003
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献